These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 10744143

  • 1. Fibrinolytic proteins and progression of coronary artery disease in relation to gemfibrozil therapy.
    Hamsten A, Syvänne M, Silveira A, Luong LA, Nieminen MS, Humphries S, Frick MH, Taskinen MR.
    Thromb Haemost; 2000 Mar; 83(3):397-403. PubMed ID: 10744143
    [Abstract] [Full Text] [Related]

  • 2. Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease.
    Grancha S, Estellés A, Tormo G, Falco C, Gilabert J, España F, Cano A, Segui R, Aznar J.
    Thromb Haemost; 1999 Apr; 81(4):516-21. PubMed ID: 10235431
    [Abstract] [Full Text] [Related]

  • 3. The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.
    Pérez-Martínez P, Adarraga-Cansino MD, Fernández de la Puebla RA, Blanco-Molina A, Delgado-Lista J, Marín C, Ordovás JM, López-Miranda J, Pérez-Jiménez F.
    Br J Nutr; 2008 Apr; 99(4):699-702. PubMed ID: 17903340
    [Abstract] [Full Text] [Related]

  • 4. Effects of gemfibrozil and ciprofibrate on plasma levels of tissue-type plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen in hyperlipidaemic patients.
    Kockx M, de Maat MP, Knipscheer HC, Kastelein JJ, Kluft C, Princen HM, Kooistra T.
    Thromb Haemost; 1997 Oct; 78(4):1167-72. PubMed ID: 9364979
    [Abstract] [Full Text] [Related]

  • 5. Plasma PAI-1 levels in obese children--effect of weight loss and influence of PAI-1 promoter 4G/5G genotype.
    Estellés A, Dalmau J, Falcó C, Berbel O, Castelló R, España F, Aznar J.
    Thromb Haemost; 2001 Aug; 86(2):647-52. PubMed ID: 11522017
    [Abstract] [Full Text] [Related]

  • 6. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
    Lahlou-Laforet K, Alhenc-Gelas M, Pornin M, Bydlowski S, Seigneur E, Benetos A, Kierzin JM, Scarabin PY, Ducimetiere P, Aiach M, Guize L, Consoli SM.
    Am J Cardiol; 2006 May 01; 97(9):1287-91. PubMed ID: 16635597
    [Abstract] [Full Text] [Related]

  • 7. Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects.
    Deepa R, Velmurugan K, Saravanan G, Dwarakanath V, Agarwal S, Mohan V.
    J Assoc Physicians India; 2002 Jul 01; 50():901-6. PubMed ID: 12126344
    [Abstract] [Full Text] [Related]

  • 8. [Effect of physical exercise training on graft patency after aortocoronary bypass grafting].
    Kubo H, Ohshima H, Hirai H, Yabuki S, Machii K, Sato K, Ebine K.
    J Cardiol; 1993 Jul 01; 23(4):319-27. PubMed ID: 8064580
    [Abstract] [Full Text] [Related]

  • 9. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
    Castelló R, España F, Vázquez C, Fuster C, Almenar SM, Aznar J, Estellés A.
    Thromb Res; 2006 Jul 01; 117(5):487-92. PubMed ID: 15907980
    [Abstract] [Full Text] [Related]

  • 10. Predictive value of fibrinolytic factors in coronary heart disease.
    Wiman B.
    Scand J Clin Lab Invest Suppl; 1999 Jul 01; 230():23-31. PubMed ID: 10389198
    [Abstract] [Full Text] [Related]

  • 11. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism, coronary thrombosis, and myocardial infarction in middle-aged Finnish men who died suddenly.
    Mikkelsson J, Perola M, Wartiovaara U, Peltonen L, Palotie A, Penttilä A, Karhunen PJ.
    Thromb Haemost; 2000 Jul 01; 84(1):78-82. PubMed ID: 10928474
    [Abstract] [Full Text] [Related]

  • 12. Plasminogen activator inhibitor 1 (PAI-1) in plasma: its role in thrombotic disease.
    Wiman B.
    Thromb Haemost; 1995 Jul 01; 74(1):71-6. PubMed ID: 8578529
    [Abstract] [Full Text] [Related]

  • 13. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
    Deng A, Gocke CD, Hess J, Heyman M, Paltiel M, Gaspari A.
    Arch Dermatol; 2006 Nov 01; 142(11):1466-9. PubMed ID: 17116837
    [Abstract] [Full Text] [Related]

  • 14. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression.
    Ramón LA, Gilabert-Estellés J, Cosín R, Gilabert J, España F, Castelló R, Chirivella M, Romeu A, Estellés A.
    Thromb Res; 2008 Nov 01; 122(6):854-60. PubMed ID: 18423526
    [Abstract] [Full Text] [Related]

  • 15. Influence of the 4G/5G PAI-1 genotype on angiotensin II-stimulated human endothelial cells and in patients with hypertension.
    Roncal C, Orbe J, Rodriguez JA, Belzunce M, Beloqui O, Diez J, Páramo JA.
    Cardiovasc Res; 2004 Jul 01; 63(1):176-85. PubMed ID: 15194475
    [Abstract] [Full Text] [Related]

  • 16. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
    Huber K, Rosc D, Resch I, Schuster E, Glogar DH, Kaindl F, Binder BR.
    Thromb Haemost; 1988 Dec 22; 60(3):372-6. PubMed ID: 3149044
    [Abstract] [Full Text] [Related]

  • 17. Comprehensive survey of common genetic variation at the plasminogen activator inhibitor-1 locus and relations to circulating plasminogen activator inhibitor-1 levels.
    Kathiresan S, Gabriel SB, Yang Q, Lochner AL, Larson MG, Levy D, Tofler GH, Hirschhorn JN, O'Donnell CJ.
    Circulation; 2005 Sep 20; 112(12):1728-35. PubMed ID: 16172282
    [Abstract] [Full Text] [Related]

  • 18. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
    Jorgenson E, Deitcher SR, Cicek M, Liu X, Plummer S, Casey G, Witte JS.
    Prostate; 2007 Feb 01; 67(2):172-7. PubMed ID: 17044080
    [Abstract] [Full Text] [Related]

  • 19. Effect of ACE inhibition on the fibrinolytic system in patients requiring coronary artery bypass grafting.
    Walter T, Szabo S, Kazmaier S, Suselbeck T, Borggrefe M, Hoffmeister HM.
    Thorac Cardiovasc Surg; 2009 Sep 01; 57(6):368-71. PubMed ID: 19707983
    [Abstract] [Full Text] [Related]

  • 20. Association of plasminogen activator inhibitor-1 4G/5G gene polymorphism with variations in the LDL particle size in healthy Japanese men.
    Kitamura Y, Okumura K, Imamura A, Mizuno T, Tsuzuki M, Numaguchi Y, Matsui H, Murohara T.
    Clin Chim Acta; 2004 Sep 01; 347(1-2):209-16. PubMed ID: 15313160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.